v3.20.2
Condensed Statements of Operations (Unaudited) - USD ($)
3 Months Ended 9 Months Ended
Sep. 30, 2020
Sep. 30, 2019
Sep. 30, 2020
Sep. 30, 2019
Revenues:        
Total Revenues $ 31,243
Selling, general and administrative expenses 1,164,089 1,157,064 3,001,720 3,989,274
Research and development expenses 758,198 676,970 1,974,995 1,418,293
Loss from Operations (1,922,287) (1,834,034) (4,976,715) (5,376,324)
Other (Income) Expense:        
Interest (income) expense, net (564) (19,139) (3,425) (41,680)
Change in fair value of derivative liabilities 53,046 (211,807)
Total Other (Income) Expense 52,482 (19,139) (215,232) (41,680)
Net Loss (1,974,769) (1,814,895) (4,761,483) (5,334,644)
Deemed dividend to Series C Preferred Stockholders (23,859) (23,859)
Net Loss Attributable to Common Stockholders $ (1,998,628) $ (1,814,895) $ (4,785,342) $ (5,334,644)
Net Loss Per Basic and Diluted Common Share: $ (0.06) $ (0.10) $ (0.19) $ (0.35)
Weighted Average Number of Common Shares Outstanding: Basic and Diluted 36,145,494 17,922,129 25,460,490 15,029,969
Royalty Income [Member]        
Revenues:        
Total Revenues $ 31,243

Source